IGF1 Genotype and Breast Cancer Risk in Young Women
Author Information
Author(s): Helena Jernström, Tina Sandberg, Elin Bågeman, Åsa Borg, Håkan Olsson
Primary Institution: Lund University Hospital
Hypothesis
The absence of the IGF1 19-repeat allele may increase breast cancer risk after hormone exposure in young women from high-risk families.
Conclusion
The absence of the IGF1 19-repeat allele is associated with larger breast volumes and may increase the risk of early-onset breast cancer in young women.
Supporting Evidence
- Absence of the IGF1 19-repeat allele was found in 13% of participants.
- Women without the 19-repeat allele had higher IGF-1 levels during hormonal contraceptive use.
- Incident breast cancers were more common in women lacking the 19-repeat allele.
Takeaway
Women who don't have a specific gene variant may have bigger breasts and a higher chance of getting breast cancer after using hormones or being pregnant.
Methodology
The study involved a prospective cohort of 258 healthy women under 40 from high-risk breast cancer families, who completed questionnaires and had their breast volumes and plasma IGF-1 levels measured.
Potential Biases
Potential selection bias as participants were from high-risk families, which may not represent the general population.
Limitations
The study had a relatively small sample size and a short follow-up period, limiting the ability to draw definitive conclusions about long-term cancer risk.
Participant Demographics
Women aged 40 years or younger from high-risk breast cancer families, including known BRCA1/2 mutation carriers and their relatives.
Statistical Information
P-Value
0.002
Confidence Interval
1.85–56.7
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website